Synfacts 2013; 9(1): 0010
DOI: 10.1055/s-0032-1317724
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart · New York

Synthesis of a Glucokinase Activator

Contributor(s):
Philip Kocienski
Dunetz JR, * Berliner MA. * et al. Pfizer Worldwide Research and Development, Groton, USA and Sandwich, UK; Asymchem Life Science Co., Tianjin, P. R. of China
Multikilogram Synthesis of a Hepatoselective Glucokinase Activator.

Org. Process Res. Dev. 2012;
16: 1635-1645
Further Information

Publication History

Publication Date:
17 December 2012 (online)

 

Significance

Glucokinase mediates glucose metabolism in the liver and insulin release in the pancreas. The target molecule selectively activates liver glucokinase with diminished risk of hypoglycemia. It is a lead for the treatment of type 2 diabetes. A major challenge in the synthesis depicted was the formation of amide I by the condensation of the racemization-prone carboxylic acid G with the weakly nucleophilic 6-aminonicotinic ester H. Best results were obtained using n-propane­sulfonic anhydride (T3P) as the condensing agent.


#

Comment

The N-alkylation of imidazole E was studied extensively to achieve high regioselectivity with minimal racemization. Best results were obtained using potassium phosphate as base and ethyl acetate as solvent, in which case the regio­selectivity was 96:4. The unwanted regioisomer and epimer was removed by crystallization of the salt prepared from (R)-α-methylbenzylamine. A further complication was the hydrolytic lability of the hard-won amide bond in I.


#
#